Call for Papers  

Article Details


Review Article

Current Status and Challenges in Rotigotine Delivery

[ Vol. 26 , Issue. 19 ]

Author(s):

Shadab Md*, Shahid Karim, Sanggetha R. Saker, Ooi A. Gie, Lim C. Hooi, Phua H. Yee, Alvin W.C. Kang, Chen K. Zhe, Ng Ian, Hibah M. Aldawsari, Khaled M. Hosny and Nabil A. Alhakamy*   Pages 2222 - 2232 ( 11 )

Abstract:


Rotigotine is a non-ergoline, high lipophilic dopamine agonist. It is indicated as the first-line therapy for Parkinson's disease (PD) and Restless Leg Syndrome (RLS). However, the precise mechanism of rotigotine is yet to be known. Rotigotine has similar safety and tolerability to the other oral non-ergolinic dopamine antagonists in clinical trials, which include nausea, dizziness and somnolence. Neupro® was the first marketed transdermal patch formulation having rotigotine. The transdermal delivery system is advantageous as it enables continuous administration of the drug, thus providing steady-state plasma drug concentration for 24-hours. Intranasal administration of rotigotine allows the drug to bypass the blood-brain barrier enabling it to reach the central nervous system within minutes. Rotigotine can also be formulated as an extended-release microsphere for injection. Some challenges remain in other routes of rotigotine administration such as oral, parenteral and pulmonary, whereby resolving these challenges will be beneficial to patients as they are less invasive and comfortable in terms of administration. This review compiles recent work on rotigotine delivery, challenges and its future perspective.

Keywords:

Rotigotine, microemulsion, microspheres, nanoparticles, transdermal delivery, Parkinson's Disease (PD).

Affiliation:

Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Department of Pharmacology, College of Medicine, King Abdulaziz University, Jeddah, 21589, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589



Read Full-Text article